Ovarian vein thrombophlebitis as a complication of second trimester abortion

In: BMJ Case Reports · 2026 · vol. 19(1) , pp. e269604 · doi:10.1136/bcr-2025-269604 · PMID:41617366 · W7126266159
article OA: closed CC0
AI-generated deep summary by claude@2026-07, 2026-07-03 · read from full text

This paper reports a rare case of ovarian vein thrombophlebitis (OVT) occurring after a second-trimester abortion at 16 weeks’ gestation, a timing where OVT is “exceedingly uncommon.” The authors describe the patient’s clinical features of pelvic pain and persistent fever, elevated inflammatory markers, and CT findings showing right ovarian vein thrombosis, noting that nonspecific symptoms can mimic conditions such as endometritis or urinary tract infection and delay diagnosis. They report successful treatment using broad-spectrum antibiotics plus anticoagulation, with a transition from low-molecular-weight heparin to rivaroxaban and complete recovery, while also emphasizing the major limitation that this is a single case report. This paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Ovarian vein thrombophlebitis (OVT) is a rare but serious complication, most often described postpartum but also possible after abortion or pelvic surgery. It represents part of a spectrum that includes ovarian vein thrombosis, OVT and septic pelvic thrombophlebitis (SPT). Clinical features are non-specific, with pelvic pain and persistent fever often mimicking endometritis, urinary tract infection or other abdominal conditions, which contributes to delayed diagnosis. Imaging, particularly contrast-enhanced CT, is crucial for confirmation.We report the case of a woman in her 20s who developed OVT after an abortion at 16 weeks' gestation, an exceedingly uncommon setting for this condition. Diagnosis was established by clinical features, inflammatory markers and CT showing right ovarian vein thrombosis. She was successfully treated with broad-spectrum antibiotics and anticoagulation, transitioning from low-molecular-weight heparin to rivaroxaban, with complete recovery.
Full text 1,968 characters · extracted from oa-doi-fallback · click to expand
Article Text Abstract Ovarian vein thrombophlebitis (OVT) is a rare but serious complication, most often described postpartum but also possible after abortion or pelvic surgery. It represents part of a spectrum that includes ovarian vein thrombosis, OVT and septic pelvic thrombophlebitis (SPT). Clinical features are non-specific, with pelvic pain and persistent fever often mimicking endometritis, urinary tract infection or other abdominal conditions, which contributes to delayed diagnosis. Imaging, particularly contrast-enhanced CT, is crucial for confirmation. We report the case of a woman in her 20s who developed OVT after an abortion at 16 weeks’ gestation, an exceedingly uncommon setting for this condition. Diagnosis was established by clinical features, inflammatory markers and CT showing right ovarian vein thrombosis. She was successfully treated with broad-spectrum antibiotics and anticoagulation, transitioning from low-molecular-weight heparin to rivaroxaban, with complete recovery. - Abortion - Pregnancy - Materno-fetal medicine - Thrombosis Statistics from Altmetric.com Footnotes Contributors The following authors were responsible for drafting of the text, sourcing and editing of clinical images, investigation results, drawing original diagrams and algorithms, and critical revision for important intellectual content: IGN, PPA, ARC and MLR. The following authors gave final approval of the manuscript: ARC. Guarantor name and preferred contact details: IGN. Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors. Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy. Competing interests None declared. Provenance and peer review Not commissioned; externally peer reviewed.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

disambig:endometritis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

References (9)

SciLite annotations

chemicals 2
heparin rivaroxaban

Source provenance

openalex
last seen: 2026-05-11T07:02:20.300321+00:00
scilite
last seen: 2026-06-21T06:47:03.627287+00:00
unpaywall
last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0 · commercial use OK